Goodrx Holdings Inc Cash Flow Reinvestment Rate

Latest as of September 2025: 0.47x

Goodrx Holdings Inc cash flow reinvestment rate. Goodrx Holdings Inc (GDRX) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting $36.00 Million (capex $18.00 Million plus investments $-18.00 Million) from operating cash flow of $76.02 Million. Explore Goodrx Holdings Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.47x
(Capex + Investments) / Operating CF

Total Reinvested

$36.00 Million
Capex + Investments

Operating Cash Flow

$76.02 Million
USD

Capital Expenditures

$18.00 Million
USD

Cash Flow Reinvestment Rate of Goodrx Holdings Inc (2018–2024)

Cash flow reinvestment rate of Goodrx Holdings Inc from 2018 to 2024. Historical reinvestment intensity for Goodrx Holdings Inc across 7 annual periods. Explore Goodrx Holdings Inc (GDRX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Goodrx Holdings Inc Cash Flow Reinvestment Rate by Year (2018–2024)

Goodrx Holdings Inc cash flow reinvestment rate by year from 2018 to 2024. Year-by-year capital reinvestment analysis for Goodrx Holdings Inc. For the full cash flow conversion analysis, see Goodrx Holdings Inc (GDRX) cash conversion ratio.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.77x $140.69 Million $183.89 Million $70.35 Million ▲ +8.7%
2023 0.70x $97.37 Million $138.29 Million $55.77 Million ▼ -61.1%
2022 1.81x $265.71 Million $146.78 Million $55.21 Million ▲ +51.8%
2021 1.19x $213.19 Million $178.78 Million $34.46 Million ▲ +22.9%
2020 0.97x $127.44 Million $131.34 Million $35.82 Million ▲ +88.8%
2019 0.51x $42.80 Million $83.29 Million $5.75 Million ▲ +236.3%
2018 0.15x $6.92 Million $45.25 Million $3.46 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow